FAP and hepatocellular carcinoma: The study indicated that miR‐500a‐3p expression levels (Figure 3E) and HSC activation markers (α‐SMA, FAP, and vimentin) were gradually boosted in LX2 cells after treatment with HCC exosomes (Figure 3F).